Orchestra BioMed CFO’s June 2026 Share Sale: Routine RSU Vesting, No Big Impact
Insider CFO Taylor Andrew Lawrence sold 36,352 Orchestra BioMed shares at $4.02 per share— a routine RSU‑driven move with negligible impact on the stock’s price or valuation.
3 minutes to read